Zur Rose (OTCMKTS:ZRSEF) Earns “Overweight” Rating from Barclays

Barclays reiterated their overweight rating on shares of Zur Rose (OTCMKTS:ZRSEF) in a report issued on Tuesday, The Fly reports.

Shares of ZRSEF opened at $310.03 on Tuesday. Zur Rose has a one year low of $259.00 and a one year high of $310.03.

Zur Rose Company Profile

Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. The company offers consumer health, beauty, and personal care products. It also provides medicines management services.

See Also: What is the significance of the death cross?

The Fly

Receive News & Ratings for Zur Rose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zur Rose and related companies with MarketBeat.com's FREE daily email newsletter.